8-17589661-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001372073.1(PDGFRL):c.249C>A(p.Thr83Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00206 in 1,613,248 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 40 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 34 hom. )
Consequence
PDGFRL
NM_001372073.1 synonymous
NM_001372073.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.273
Genes affected
PDGFRL (HGNC:8805): (platelet derived growth factor receptor like) This gene encodes a protein with significant sequence similarity to the ligand binding domain of platelet-derived growth factor receptor beta. Mutations in this gene, or deletion of a chromosomal segment containing this gene, are associated with sporadic hepatocellular carcinomas, colorectal cancers, and non-small cell lung cancers. This suggests this gene product may function as a tumor suppressor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 8-17589661-C-A is Benign according to our data. Variant chr8-17589661-C-A is described in ClinVar as [Benign]. Clinvar id is 714376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.273 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1652/152248) while in subpopulation AFR AF= 0.0381 (1580/41522). AF 95% confidence interval is 0.0365. There are 40 homozygotes in gnomad4. There are 732 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDGFRL | NM_001372073.1 | c.249C>A | p.Thr83Thr | synonymous_variant | 2/6 | ENST00000251630.11 | NP_001359002.1 | |
PDGFRL | NM_006207.2 | c.249C>A | p.Thr83Thr | synonymous_variant | 3/7 | NP_006198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDGFRL | ENST00000251630.11 | c.249C>A | p.Thr83Thr | synonymous_variant | 2/6 | 5 | NM_001372073.1 | ENSP00000251630.4 | ||
PDGFRL | ENST00000541323.1 | c.249C>A | p.Thr83Thr | synonymous_variant | 3/7 | 2 | ENSP00000444211.1 | |||
PDGFRL | ENST00000673645.1 | c.249C>A | p.Thr83Thr | synonymous_variant | 3/4 | ENSP00000501219.1 |
Frequencies
GnomAD3 genomes AF: 0.0108 AC: 1649AN: 152130Hom.: 39 Cov.: 31
GnomAD3 genomes
AF:
AC:
1649
AN:
152130
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00283 AC: 711AN: 251362Hom.: 12 AF XY: 0.00214 AC XY: 291AN XY: 135886
GnomAD3 exomes
AF:
AC:
711
AN:
251362
Hom.:
AF XY:
AC XY:
291
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00114 AC: 1672AN: 1461000Hom.: 34 Cov.: 31 AF XY: 0.000993 AC XY: 722AN XY: 726846
GnomAD4 exome
AF:
AC:
1672
AN:
1461000
Hom.:
Cov.:
31
AF XY:
AC XY:
722
AN XY:
726846
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0109 AC: 1652AN: 152248Hom.: 40 Cov.: 31 AF XY: 0.00983 AC XY: 732AN XY: 74432
GnomAD4 genome
AF:
AC:
1652
AN:
152248
Hom.:
Cov.:
31
AF XY:
AC XY:
732
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at